Navigation Links
Heart attack patients who stop statin risk death, say McGill researchers
Date:8/27/2008

This release is available in French.

Patients discontinuing statin medication following an acute myocardial infarction (AMI) increase their risk of dying over the next year, say researchers at McGill University and the McGill University Health Centre (MUHC). Their study was published in a recent issue of the European Heart Journal.

Using data on British patients who survived an AMI and were still alive three months later, Dr. Stella Daskalopoulou and colleagues found that those who discontinued their statin medication were 88% more likely to die during the following year compared to those who had never been on the medication.

"Statins were found to be beneficial drugs," said Dr. Daskalopoulou, of McGill's Faculty of Medicine and the Department of Medicine and the Division of Clinical Epidemiology at the MUHC. "Patients who used statins before an AMI and continued to take them after were 16% less likely to die over the next year than those who never used them. So even if it appears that the statins failed to prevent your AMI, it is beneficial to continue taking them and potentially quite harmful to stop."

The large, population-based cohort study was conducted using UK data to take advantage of the medical records kept in the General Practice Research Database (GPRD), which collects information on the health of more than three million patients across the UK.

"In the general population the statin discontinuation rate within the first year of prescription is 30 percent. That's very high," Dr. Daskalopoulou continued. "Because statins are preventative drugs, patients may not feel the immediate benefit of taking them and sometimes stop. However, it looks like this might be quite a dangerous practice after an AMI."

The harmful effects of statin discontinuation may be the result of many different mechanisms, includ
'/>"/>

Contact: Mark Shainblum
mark.shainblum@mcgill.ca
514-398-2189
McGill University
Source:Eurekalert

Page: 1 2

Related medicine news :

1. University Hospitals Case Medical Center recognized by American Heart Association
2. Vitamin B, Folate Supplements Wont Help Heart
3. Ultrasound used to predict heart attack risk
4. Reaching the Heart Through the Wrist
5. Air Pollution Can Damage Heart, Blood Vessels, Too
6. Infant Heart Transplant Controversy Continues
7. Morpace Inc. Reports: Hispanic American Women Unaware of Heart Disease Threat
8. Kaiser Permanente - Stanford Heart Research Center Funded to Study Treatment Outcomes
9. Turbulence Predicts Death Risk for Heart Failure Patients
10. Fat Cell Protein Boosts Heart Attack Risk in Elderly
11. New implant device remotely monitors heart failure patients at Northwestern Memorial
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/30/2015)... Sierra Madre, CA (PRWEB) , ... June 30, ... ... held the company’s first UHMS approved 40-hour Introduction to Hyperbaric Medicine Course. Clinicians ... jam packed weekend of hyperbaric medicine curriculum. , Wound care and hyperbaric ...
(Date:6/30/2015)... ... June 30, 2015 , ... The LIV Fertility ... fertility preservation and deciding the right age to pursue egg freezing. Statistics show that ... age of 35 — a 150 percent increase since the 1970s. , Sadly, for ...
(Date:6/30/2015)... ... 30, 2015 , ... University Post-Acute Rehab recently released a ... rehab center’s patients and their experiences at the facility. Medicare granted University Post-Acute ... Each patient attests to the high rating, which is predominantly based on cleanliness, ...
(Date:6/30/2015)... ... June 30, 2015 , ... Lakeview Health, ... than doubled the size of its medical staff to further enhance its ability ... includes physicians, nurse practitioners and physician assistants -- now totals 17, compared to ...
(Date:6/30/2015)... ... June 30, 2015 , ... Rocky Mountain Oils, a leading ... management team and added a new CEO, Mr. Darold Francis. The changes will help ... premium essential oils that customers have come to know and respect for over eight ...
Breaking Medicine News(10 mins):Health News:Wound Care Advantage Hosts Its First UHMS Approved 40-Hour Introduction to Hyperbaric Medicine Course 2Health News:Wound Care Advantage Hosts Its First UHMS Approved 40-Hour Introduction to Hyperbaric Medicine Course 3Health News:LIV Fertility Center Educating Women on the Critical Timing of Egg Freezing 2Health News:LIV Fertility Center Educating Women on the Critical Timing of Egg Freezing 3Health News:LIV Fertility Center Educating Women on the Critical Timing of Egg Freezing 4Health News:LIV Fertility Center Educating Women on the Critical Timing of Egg Freezing 5Health News:Patients of University Post-Acute Rehab Support Five-Star Rating in New Video 2Health News:Lakeview Health, a Nationally Recognized Drug Rehabilitation Center in Florida, Doubles Size of Medical Staff 2Health News:Rocky Mountain Oils Adds New CEO, Announces Relocation of Operations to Orem, Utah 2
... suggest drug makers exaggerate benefits for women who do ... -- Drug companies exaggerate the benefits and downplay the ... are weakened but who do not have osteoporosis, a ... and risedronate do reduce the risk of fractures of ...
... funding promotes diabetes care improvement at a community-level, ... throughout the,U.S. in implementing and evaluating models for ... Business Coalition on Health,(NBCH) announced the recipients of ... for NBCH member coalitions -- intended to support ...
... 18 VNUS(R) Medical,Technologies, Inc. (Nasdaq: VNUS ), ... treatment of venous reflux disease, today,announced the appointment of ... Finance and Administration., Mr. Osborne joins VNUS with ... roles. Mr. Osborne had served as the Company,s,Interim CFO ...
... (BRONX, NY) Stanley G. Nathenson, M.D., distinguished professor ... the Albert Einstein College of Medicine of Yeshiva University, ... Faculty Prize for Research Excellence during a special ceremony ... established in memory of a beloved long-time member of ...
... what is recommended and what is achieved in daily ... Prof Guy De Backer, Chairman of the CVD ... summarises the aim of the European Summit on Cardiovascular ... make healthy choices in every European country is the ...
... diagnostic tool to detect surface cancers quickly and ... calculate body composition has been developed by a ... from QUTs School of Physical and Chemical Sciences ... spectroscopy to diagnose cervical and skin cancers. , ...
Cached Medicine News:Health News:Bone-Strengthening Drugs May Be Overprescribed 2Health News:Bone-Strengthening Drugs May Be Overprescribed 3Health News:National Business Coalition on Health Awards Grants to 14 Coalitions for Diabetes Quality Programs 2Health News:National Business Coalition on Health Awards Grants to 14 Coalitions for Diabetes Quality Programs 3Health News:VNUS Medical Technologies Appoints Peter Osborne as Chief Financial Officer 2Health News:Einstein honors Dr. Stanley Nathenson with Marshall S. Horwitz Faculty Prize for Research Excellence 2Health News:European Summit on Cardiovascular Disease Prevention 2
(Date:6/30/2015)... June 30, 2015   Millar, Inc. , a ... announced the 2016 retirement of Craig Thummel , ... 12 years of service to the Company. The Company ... senior members of the Executive Management team as his ... Daugherty , currently Director of Sales and Marketing, as ...
(Date:6/30/2015)... NEW YORK , June 30, 2015 /PRNewswire/ ... a late stage pharmaceutical company focused on the ... today announced the closing of its previously announced ... stock. The underwriters also exercised their over-allotment option ... of common stock. The net proceeds ...
(Date:6/30/2015)... June 24, 2015 ... addition of the "Global Array Instruments Market ... The global array instruments market to grow at ... 2014-2019 The global array instruments market can ... microarrays, and others including tissue microarrays and cell ...
Breaking Medicine Technology:Millar, Inc. Announces Leadership Changes 2Millar, Inc. Announces Leadership Changes 3Dipexium Announces Closing of Public Offering of Common Stock 2Dipexium Announces Closing of Public Offering of Common Stock 3Global Array Instruments Market 2015-2019 - Advances in Personalized Medicines with Affymetrix, Agilent Technologies & Illumina Dominating 2
... Roche announced today the opening of a new ... Nutley, N.J. The Roche Center of Excellence produces dosage ... and Phase 1 and 2 clinical studies. The 17,000 ... compounds into medicines for clinical trials. ...
... Sept. 30, 2011 The CyberKnife Coalition ... the CyberKnife Robotic Radiosurgery System® have now been enrolled ... track prostate cancer patients treated with stereotactic ... Radiosurgery (RPCR), tracks clinical and functional outcomes of men ...
Cached Medicine Technology:Roche Opens New Center of Excellence Facility 2First Prostate Cancer Registry for Robotic Radiosurgery Patients Enrolls More than 500 Men 2
... scaleable device that works with ... plasma or buffy coat. The ... must be prepared independently using ... volume and concentration factor can ...
Avitene Microfibrillar Collagen (MCH) is used in surgical procedures as an adjunct to hemostasis when control of bleeding by ligature or conventional procedures is ineffective or impractical....
The Ultrafoam Collagen Sponge is indicated in all surgical procedures as an adjunct to hemostasis when control by ligature or conventional procedures are ineffective or impractical....
Exclusive oxidized regenerated cellulose technology. The only oxidized regenerated cellulose hemostat line, surgicel absorbable hemostat delivers a unique combination of effectiveness, absorbability,...
Medicine Products: